India’s CGM devices market eyes 5% CAGR growth through 2035

The country accounts for around 5% of the Asia Pacific market.

India’s continuous glucose monitoring (CGM) devices market is projected to expand at a compound annual growth rate of 5% until 2035, according to a GlobalData report.

The country accounts for around 5% of the Asia Pacific market.

“Affordable, homegrown CGM technologies are breaking long-standing barriers of cost and accessibility,” said Shagufta Hasan, Medical Devices Analyst at GlobalData.

One driver is a real-time, minimally invasive device developed by the Indian Institute of Technology Madras and the Thin Films Lab for use in Indian patients.

However, the affordability of existing CGM systems, integration within digital health ecosystems, and the need for stronger reimbursement and clinical adoption frameworks may challenge market growth.